IMVTW

Immunovant (IMVTW)

Immunovant Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IMVTW

1 2 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2020/05/18	21 : 52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMVTW	Immunovant Inc
2020/05/18	21 : 48	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMVTW	Immunovant Inc
2020/05/18	21 : 42	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMVTW	Immunovant Inc
2020/05/18	21 : 41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMVTW	Immunovant Inc
2020/05/18	21 : 37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMVTW	Immunovant Inc
2020/05/18	21 : 32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMVTW	Immunovant Inc
2020/05/18	21 : 28	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMVTW	Immunovant Inc
2020/05/18	21 : 26	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMVTW	Immunovant Inc
2020/05/18	21 : 23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMVTW	Immunovant Inc
2020/05/15	19 : 21	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:IMVTW	Immunovant Inc
2020/05/15	08 : 26	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMVTW	Immunovant Inc
2020/05/14	21 : 21	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IMVTW	Immunovant Inc
2020/04/18	06 : 29	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMVTW	Immunovant Inc
2020/04/18	06 : 28	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:IMVTW	Immunovant Inc
2020/04/15	19 : 01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:IMVTW	Immunovant Inc
2020/04/15	06 : 28	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	NASDAQ:IMVTW	Immunovant Inc
2020/04/15	06 : 25	Edgar (US Regulatory)	Post-effective Amendment Filed Solely to Add Exhibits to a Registration Statement (pos Ex)	NASDAQ:IMVTW	Immunovant Inc
2020/04/14	22 : 07	Edgar (US Regulatory)	Registration of Additional Securities (up to 20%) (s-1mef)	NASDAQ:IMVTW	Immunovant Inc
2020/04/10	20 : 44	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:IMVTW	Immunovant Inc
2020/04/10	19 : 10	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:IMVTW	Immunovant Inc
2020/04/10	19 : 01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:IMVTW	Immunovant Inc
2020/04/10	06 : 13	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:IMVTW	Immunovant Inc
2020/04/10	01 : 17	Edgar (US Regulatory)	Other Filing	NASDAQ:IMVTW	Immunovant Inc
2020/04/10	01 : 16	Edgar (US Regulatory)	Other Filing	NASDAQ:IMVTW	Immunovant Inc
2020/04/08	21 : 41	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:IMVTW	Immunovant Inc
2020/04/03	19 : 02	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:IMVTW	Immunovant Inc
2020/03/31	06 : 17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IMVTW	Immunovant Inc
2020/02/29	07 : 38	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:IMVTW	Immunovant Inc
2020/02/27	07 : 04	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:IMVTW	Immunovant Inc
2020/02/20	07 : 32	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:IMVTW	Immunovant Inc